QSIAW
Quantum-Si incorporated
NASDAQ · Healthcare · Biotechnology · US
$0.20
+0.00%Year over year
Reported trailing growth
- Revenue
- -46.2%
- EBITDA
- +13.5%
- EBIT
- +12.7%
- EPS
- +24.4%
- Free cash flow
- -0.1%
- Operating cash flow
- -3.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +50.0%
- EBITDA
- +3.6%
- EBIT
- +10.3%
- Net income
- -0.3%
- EPS
- +28.2%
- Free cash flow
- -5.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026